Powered by

Bakers and Davis Polk lead on billion-dollar sale of cancer drugs unit

Apr 17, 2018 - The Lawyer

Baker McKenzie has advised French pharmaceutical company Servier in its $2.4bn purchase of Shire's oncology business, while Davis Polk & Wardwell was on hand for the latter.

Baker McKenzie has advised French pharmaceutical company Servier in its $2.4bn purchase of Shire's oncology business, while Davis Polk & Wardwell was on hand for the latter.

The announcement of the deal could deter Takeda Pharmaceuticals, which publicly announced its interest in Shire at the end of last month and...